Related Experiment Videos
Human tears inhibit the coating of proteins to solid phase surfaces
Current Eye Research
|November 1, 1985
Summary
Human tears contain surfactants that inhibit protein binding in ELISA tests. This new method detects tear surfactants, aiding research into tear film disorders.
Area of Science:
- Ophthalmology
- Biochemistry
- Immunology
Background:
- Surfactants play a crucial role in tear film stability.
- Understanding tear composition is vital for diagnosing and managing dry eye disease and other tear film disorders.
Purpose of the Study:
- To investigate the presence and characteristics of surfactants in human tear samples.
- To develop a sensitive method for analyzing tear surfactant activity.
Main Methods:
- Enzyme-Linked Immunosorbent Assay (ELISA) technology was adapted to study tear samples.
- Experiments involved incubating tear samples with polyacrylate microcuvettes and purified lactoferrin.
- The effect of tear fractions on antibody binding was assessed to characterize inhibitory activity.
Main Results:
- Human tears demonstrated a dose-dependent inhibition of lactoferrin binding to microcuvettes.
- A "coating inhibitory activity" was identified in tears, attributed to a factor binding to the solid phase.
- The findings suggest the presence of lacrimal surfactants similar to those previously observed.
Conclusions:
- A novel ELISA-based method can quantify tear surfactant activity using minimal tear samples.
- This method is suitable for biochemical analysis and clinical studies of tear film disorders.